explore -WSS

explore

author：Wikipedia 2025-09-29 10:40:25 - browse：73579

Peter Marks, Director of the Center for Biologics Evaluation and Research at the US Food and Drug Administration (FDA), testifies during a Senate Health, Education, Labor and Pensions Committee hearing to discuss the on-going federal response to Covid-19 on May 11, 2021 at the US Capitol in Washington, DC. — FDA's Peter Marks JIM LO SCALZO/POOL/AFP via Getty Images

WASHINGTON — The Food and Drug Administration needs dozens more reviewers if it wants its so-called Operation Warp Speed for rare disease therapies to take off, the agency’s biologics chief said Monday.

The administration launched the rare disease pilot program, dubbed START and modeled after the record race for a Covid-19 vaccine, this September. Peter Marks, head of the Center for Biologics Evaluation and Research, has spearheaded both initiatives.

“If we were really to expand this significantly, [it] would require us to get dozens of additional staff members,” Marks told listeners during a gene therapy discussion hosted by the Alliance for a Stronger FDA. “One could say ‘Oh my goodness, he’s asking for more headcount again.’ Well, if this really does reduce the time to development by 25 to 50% … it probably won’t take industry too long to do a net present value calculation to say ‘Oh, it’s worth making sure that they have their extra 20 or 30 or 40 reviewers.’”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： RaDonda Vaught case: a double standard for nurses, physicians

WSS

Nurses recount patients attacks

Can food be medicine? And other questions about a new push

Community addresses injustice for Long Island mothers

Van's Gluten Free Original Waffles recalled for possible wheat allergen

U.K. researchers warn about biases in medical devices, algorithms

Meta looks to target Twitter with a rival app called Threads

explore

explore

hotspot

What does generative AI mean for health care? We asked experts

Intermittent fasting comes with a heart risk? Not so fast

Anesthesiologist group: stop taking Ozempic before surgery

Methadone treatment changes are coming. Do they go far enough?

In age of alternative facts, a scholarly course on calling out crap

Stop the failed accountable care organization experiment

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

State Dept. review finds Biden bears some blame for Afghanistan failures

Did the public have the right to know Arthur Ashe had AIDS?

explore

Inside the fall of star MIT scientist David Sabatini

Community addresses injustice for Long Island mothers

Bacterial infection may be ‘key event’ in endometriosis, study says

Doctor appointment wait times are getting worse

Listen: PBM conflicts, RSV vaccines, & the future of flu season

Orchard's therapy for neuron disease in children wins FDA approval

hotspot

knowledge

hotspot

hotspot